216 related articles for article (PubMed ID: 32938321)
1. Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus.
Yue R; Gurung I; Long XX; Xian JY; Peng XB
Lupus; 2020 Nov; 29(13):1743-1751. PubMed ID: 32938321
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia.
Kanapathy A; Nik Jaafar NR; Shaharir SS; Chan LF; Rozita M; Ch'ng SS
Lupus; 2019 Jun; 28(7):854-861. PubMed ID: 31159651
[TBL] [Abstract][Full Text] [Related]
4. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
5. Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction.
Gulati G; Iffland PH; Janigro D; Zhang B; Luggen ME
Clin Rheumatol; 2016 Dec; 35(12):2989-2997. PubMed ID: 27357716
[TBL] [Abstract][Full Text] [Related]
6. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
7. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
[TBL] [Abstract][Full Text] [Related]
8. Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies.
Schwarting A; Möckel T; Lütgendorf F; Triantafyllias K; Grella S; Boedecker S; Weinmann A; Meineck M; Sommer C; Schermuly I; Fellgiebel A; Luessi F; Weinmann-Menke J
Ann Rheum Dis; 2019 Sep; 78(9):1226-1234. PubMed ID: 31186256
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Disease Activity, Levels of IFN-a, IL-4, IL-6, and Anti-NMDA to Cognitive Dysfunction (MoCA-INA Score) in Systemic Lupus Erythematosus (SLE) Patients with Cognitive Dysfunction.
Suntoko B; Hadisaputro S; Kalim H; Hadi S; Saputra WA
Acta Med Indones; 2023 Jul; 55(3):307-314. PubMed ID: 37915160
[TBL] [Abstract][Full Text] [Related]
10. Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study.
Park DJ; Takahashi Y; Kang JH; Yim YR; Kim JE; Lee JW; Lee KE; Lee JK; Lee SS
Clin Exp Rheumatol; 2017; 35 Suppl 105(3):54-60. PubMed ID: 28339361
[TBL] [Abstract][Full Text] [Related]
11. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Lapteva L; Nowak M; Yarboro CH; Takada K; Roebuck-Spencer T; Weickert T; Bleiberg J; Rosenstein D; Pao M; Patronas N; Steele S; Manzano M; van der Veen JW; Lipsky PE; Marenco S; Wesley R; Volpe B; Diamond B; Illei GG
Arthritis Rheum; 2006 Aug; 54(8):2505-14. PubMed ID: 16868971
[TBL] [Abstract][Full Text] [Related]
12. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis.
Baptista TSA; Petersen LE; Molina JK; de Nardi T; Wieck A; do Prado A; Piovesan DM; Keisermann M; Grassi-Oliveira R; Bauer ME
Clin Rheumatol; 2017 Sep; 36(9):1959-1968. PubMed ID: 28656478
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
Conti F; Alessandri C; Perricone C; Scrivo R; Rezai S; Ceccarelli F; Spinelli FR; Ortona E; Marianetti M; Mina C; Valesini G
PLoS One; 2012; 7(3):e33824. PubMed ID: 22461897
[TBL] [Abstract][Full Text] [Related]
15. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.
Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B
EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cognitive impairment and cognitive improvement in patients with systemic lupus erythematosus during a 6-month follow-up study.
Koolvisoot A; Chumjang S
Lupus; 2023 Sep; 32(10):1199-1210. PubMed ID: 37592859
[TBL] [Abstract][Full Text] [Related]
17. Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly.
Chalhoub NE; Luggen ME
Lupus; 2019 Jan; 28(1):51-58. PubMed ID: 30482092
[TBL] [Abstract][Full Text] [Related]
18. Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
Nantes SG; Su J; Dhaliwal A; Colosimo K; Touma Z
J Rheumatol; 2017 Nov; 44(11):1583-1589. PubMed ID: 28864643
[TBL] [Abstract][Full Text] [Related]
19. Accelerated immune aging was correlated with lupus-associated brain fog in reproductive-age systemic lupus erythematosus patients.
Kalim H; Pratama MZ; Mahardini E; Winoto ES; Krisna PA; Handono K
Int J Rheum Dis; 2020 May; 23(5):620-626. PubMed ID: 32107852
[TBL] [Abstract][Full Text] [Related]
20. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]